CARDIO DIAGNOSTICS HOLDINGS (CDIO)
US14159C1036 - Common Stock
Taking everything into account, CDIO scores 2 out of 10 in our fundamental rating. CDIO was compared to 565 industry peers in the Biotechnology industry. The financial health of CDIO is average, but there are quite some concerns on its profitability. CDIO is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CDIO has reported negative net income.
CDIO had a negative operating cash flow in the past year.
1.2 Ratios
CDIO has a Return On Assets of -219.44%. This is amonst the worse of the industry: CDIO underperforms 91.62% of its industry peers.
The Return On Equity of CDIO (-285.29%) is worse than 74.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -219.44% | ||
| ROE | -285.29% | ||
| ROIC | N/A |
ROA(3y)-106.21%
ROA(5y)N/A
ROE(3y)-149.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin and Operating Margin and Gross Margin are not available for CDIO so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
CDIO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CDIO has more shares outstanding
Compared to 1 year ago, CDIO has an improved debt to assets ratio.
2.2 Solvency
CDIO has an Altman-Z score of -8.43. This is a bad value and indicates that CDIO is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -8.43, CDIO is not doing good in the industry: 72.55% of the companies in the same industry are doing better.
CDIO has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
CDIO has a Debt to Equity ratio of 0.03. This is comparable to the rest of the industry: CDIO outperforms 41.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -8.43 |
ROIC/WACCN/A
WACC10.31%
2.3 Liquidity
A Current Ratio of 5.69 indicates that CDIO has no problem at all paying its short term obligations.
With a Current ratio value of 5.69, CDIO perfoms like the industry average, outperforming 59.89% of the companies in the same industry.
A Quick Ratio of 5.69 indicates that CDIO has no problem at all paying its short term obligations.
With a decent Quick ratio value of 5.69, CDIO is doing good in the industry, outperforming 60.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.69 | ||
| Quick Ratio | 5.69 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 26.32% over the past year.
EPS 1Y (TTM)26.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.62%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%293.5%
3.2 Future
Based on estimates for the next years, CDIO will show a very strong growth in Earnings Per Share. The EPS will grow by 27.03% on average per year.
CDIO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 467.90% yearly.
EPS Next Y29.68%
EPS Next 2Y27.03%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year168.86%
Revenue Next 2Y96.12%
Revenue Next 3Y467.9%
Revenue Next 5YN/A
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
CDIO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CDIO. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
CDIO's earnings are expected to grow with 27.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.03%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for CDIO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CARDIO DIAGNOSTICS HOLDINGS
NASDAQ:CDIO (11/22/2024, 8:00:02 PM)
After market: 0.2659 +0 (+0.19%)0.2654
+0.02 (+7.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap8.12M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -219.44% | ||
| ROE | -285.29% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.01
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 5.69 | ||
| Quick Ratio | 5.69 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)26.32%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y29.68%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y